Anette Bygum

9PUBLICATIONS
71CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesBehavioural epidemiologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 28, 2024
Microfibrillar-associated protein 4 as a predictive biomarker of treatment response in patients with chronic inflammatory diseases initiating biologics: secondary analyses based on the prospective BELIEVE cohort study.

Bjørk K Sofíudóttir, Heidi L Munk, Robin Christensen

|Jul 08, 2024
Effects of smoking on clinical treatment outcomes amongst patients with chronic inflammatory diseases initiating biologics: secondary analyses of the prospective BELIEVE cohort study.

Maja Graves Rosenkilde Larsen, Silja Hvid Overgaard, Sofie Ronja Petersen

|Aug 09, 2020
Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital.

Amalie Hartvig Pall, Anne Fog Lomholt, Christian von Buchwald

|Jul 07, 2020
The impact of adolescents' everyday life experiences on their primary hyperhidrosis treatment - a qualitative study.

Bettina Trettin, Julie Hansen, Anette Bygum

|Apr 06, 2020
Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence.

Marcus Maurer, Werner Aberer, Rosana Agondi

|Jan 08, 2020
ACE-Inhibitor Related Angioedema Is Not Sufficiently Reported to the Danish Adverse Drug Reactions Database.

Johan Emil Lundbek Cornwall, Anette Bygum, Eva Rye Rasmussen

Pageof 2

Frequent Collaborators

4 joint publications

Eva Rye Rasmussen

2 joint publications

Mia Wadelius

2 joint publications

Jens Frederik Dahlerup

2 joint publications

Anders Bathum Nexøe